Cohance Lifesciences (BOM:543064) YoY EBITDA Growth : -3.85% (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Cohance Lifesciences YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Cohance Lifesciences's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was -3.85%.

Cohance Lifesciences's EBITDA per Share for the three months ended in Mar. 2025 was ₹3.42.

Cohance Lifesciences YoY EBITDA Growth Historical Data

The historical data trend for Cohance Lifesciences's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cohance Lifesciences YoY EBITDA Growth Chart

Cohance Lifesciences Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

YoY EBITDA Growth

Get a 7-Day Free Trial

13.46

40.21

-12.96

-24.60

-6.86

Cohance Lifesciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															-51.85	-44.99	-0.47	64.27	-3.85

Cohance Lifesciences YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Cohance Lifesciences's YoY EBITDA Growth for the fiscal year that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (A: Mar. 2025 )
=	(EBITDA per Share (A: Mar. 2025 )	-	EBITDA per Share (A: Mar. 2024 ))	/	\| EBITDA per Share (A: Mar. 2024 ) \|
=	(17.12	-	18.38)	/	\| 18.38 \|
=	-6.86 %

Cohance Lifesciences's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(3.418	-	3.555)	/	\| 3.555 \|
=	-3.85 %

Cohance Lifesciences YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Cohance Lifesciences's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Cohance Lifesciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cohance Lifesciences Ltd (BOM:543064) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

COHANCE:India

Address

Hitech City Road, Panmaktha Plot, 1, 202, 2nd Floor, B-Wing, Galaxy by Aurobindo Realty, Sy No 83/1, Hyderabad Knowledge City TSIIC Raidurg, Opposite IKEA, Hyderabad, TG, IND, 500081

Website

https://www.cohance.com

Cohance Lifesciences Ltd is a CDMO and API platform, offering products and services across all phases of a molecule's lifecycle from development to commercialization. Its Business Units comprise: CDMO, API+ and Formulations, and Clinical and Analytical Services.

Cohance Lifesciences Headlines

No Headlines